IMMX 10-Q: SEC filing
Immix Biopharma
Filed with the SEC on · accession 0001493152-26-051383
IMMX filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -6.8% by the first close after the filing.
Summary of the filing
Immix Biopharma filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing financing activities including ATM sales and securities purchase agreements.
Key details
How IMMX stock reacted
Close before
$8.66
Nov 11, 2026
First close after
-6.81%
$8.07
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IMMX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMMX?
Click hereFrequently asked questions
What did IMMX file with the SEC on Nov 12, 2026?
IMMX filed a 10-Q (SEC filing). Immix Biopharma filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing financing activities including ATM sales and securities purchase agreements.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did IMMX stock react to this filing?
IMMX closed at $8.66 before the filing and $8.07 on Nov 12, 2026 (-6.81%).
Other IMMX SEC filings
Get alerts when IMMX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days